This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Bio-Reference Laboratories, Inc. Responds To An Employee Wrongful Termination Suit Filed Against It As Baseless And Without Merit

ELMWOOD PARK, N.J., April 12, 2013 (GLOBE NEWSWIRE) -- Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) strongly denounced and denied the allegations of a complaint that has been filed against the Company in the Superior Court of New Jersey by an apparently disgruntled, former employee. The Company has indicated that it will vigorously defend this case, if it proceeds, and will seek to vindicate itself through all means against the frivolous allegations.

The Company noted that earlier this week a web-based blog had posted the complaint against the Company, which has not yet been served on the Company and was unknown to the Company prior to the blog report. However, based on what was posted on the blog, the Company has completed a preliminary review of the allegations and has determined that the complaint is baseless, frivolous and totally without merit. The complaint describes a series of events that are unsupported by facts and seeks compensation for non-existent damages. The Company has policies and procedures in place that are designed to prevent the possibility of compliance violations along the lines of those alleged and that it has quality assurance programs in place that verify full compliance during the period of time alleged in the complaint. The Company's preliminary review of all electronic requisitions (the method that was used in this office) submitted by the account during the time when the plaintiff was assigned at that office to be a phlebotomist reveals no apparent Medicare or other billing issues. The Company believes it has found no evidence that any Medicare patients, drawn by the physician's staff, were billed by the Company to Medicare for venipuncture fees.  The Company also believes, based on its preliminary review that the totality of blood draws involving the plaintiff are miniscule in number and the amount of anticipated reimbursement from those phlebotomy services billed to Medicare from the account over the period the plaintiff worked at the location was less than $250. In addition, the Company believes that the billing practices relating to this account are consistent and compliant with Medicare and Medicaid regulations.

Stock quotes in this article: BRLI 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 16,501.65 0.00 0.00%
S&P 500 1,878.61 +3.22 0.17%
NASDAQ 4,148.3380 +21.3710 0.52%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs